electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.
Company profile
Ticker
ECOR
Exchange
Website
CEO
Francis Amato
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
Former names
ElectroCore, LLC
SEC CIK
Corporate docs
Subsidiaries
electroCore Germany GmbH • electroCore UK Ltd. ...
ECOR stock data
Latest filings (excl ownership)
S-8
Registration of securities for employees
13 Mar 24
10-K
2023 FY
Annual report
13 Mar 24
8-K
Record full year 2023 net sales of $16.0 million increased 87% over $8.6 million for the full year 2022
13 Mar 24
8-K
Results of Operations and Financial Condition
16 Jan 24
8-K
Departure of Directors or Certain Officers
14 Dec 23
8-K
Other Events
27 Nov 23
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Record third quarter 2023 net sales of $4.5 million, an increase of approximately 128% over third quarter 2022
8 Nov 23
424B3
Prospectus supplement
1 Sep 23
EFFECT
Notice of effectiveness
1 Sep 23
Transcripts
ECOR
Earnings call transcript
2023 Q3
8 Nov 23
ECOR
Earnings call transcript
2023 Q2
9 Aug 23
ECOR
Earnings call transcript
2023 Q1
3 May 23
ECOR
Earnings call transcript
2022 Q4
8 Mar 23
ECOR
Earnings call transcript
2022 Q3
3 Nov 22
ECOR
Earnings call transcript
2022 Q2
7 Aug 22
ECOR
Earnings call transcript
2022 Q1
9 May 22
ECOR
Earnings call transcript
2021 Q4
11 Mar 22
ECOR
Earnings call transcript
2021 Q3
7 Nov 21
ECOR
Earnings call transcript
2021 Q3
4 Nov 21
Latest ownership filings
SC 13G/A
AWM Investment Company, Inc.
14 Feb 24
4
Daniel S Goldberger
18 Jan 24
4
BRIAN M POSNER
17 Jan 24
4
Charles Steve Theofilos
3 Jan 24
3
Charles Steve Theofilos
18 Dec 23
SC 13D
Theofilos Charles Steve
18 Dec 23
SC 13G
Theofilos Charles Steve
7 Dec 23
4
Daniel S Goldberger
19 Sep 23
4
Thomas J. Errico
8 Aug 23
4
Patricia Wilber
8 Aug 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 27.17 mm | 27.17 mm | 27.17 mm | 27.17 mm | 27.17 mm | 27.17 mm |
Cash burn (monthly) | (no burn) | 1.36 mm | 1.38 mm | 1.77 mm | 791.00 k | 1.30 mm |
Cash used (since last report) | n/a | 9.40 mm | 9.48 mm | 12.19 mm | 5.45 mm | 8.93 mm |
Cash remaining | n/a | 17.77 mm | 17.69 mm | 14.98 mm | 21.72 mm | 18.24 mm |
Runway (months of cash) | n/a | 13.0 | 12.9 | 8.5 | 27.5 | 14.1 |
Institutional ownership, Q3 2023
30.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 23 |
Opened positions | 4 |
Closed positions | 1 |
Increased positions | 9 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 5.35 bn |
Total shares | 1.84 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Core Ventures II | 920.03 k | $1.44 mm |
AWM Investment | 550.36 k | $3.34 bn |
Vanguard | 148.35 k | $900.48 mm |
Geode Capital Management | 51.85 k | $314.82 mm |
Sontag Advisory | 47.50 k | $288.31 mm |
Renaissance Technologies | 42.62 k | $259.00 k |
Jaffetilchin Investment Partners | 25.10 k | $152.33 mm |
Susquehanna International | 16.10 k | $97.71 mm |
International Assets Investment Management | 15.90 k | $93.17 mm |
STT State Street | 13.07 k | $79.35 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jan 24 | Goldberger Daniel S | Common Stock | Grant | Acquire A | No | No | 0 | 75,000 | 0.00 | 211,060 |
12 Jan 24 | Posner Brian M | Common Stock | Buy | Acquire P | No | No | 0 | 16,000 | 0.00 | 22,437 |
1 Jan 24 | Theofilos Charles Steve | Common Stock | Grant | Acquire A | No | No | 0 | 25,210 | 0.00 | 437,620 |
15 Sep 23 | Goldberger Daniel S | Common Stock | Buy | Acquire P | No | No | 5.555 | 1,500 | 8.33 k | 136,060 |